Publicacions (33) Publicacions en què ha participat algun/a investigador/a

2005

  1. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas

    Genes Chromosomes and Cancer, Vol. 43, Núm. 4, pp. 414-423

  2. Anticoagulant treatment and survival in cancer patients. The evidence from clinical studies

    Haematologica, Vol. 90, Núm. 9, pp. 1258-1266

  3. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells

    Cancer Research, Vol. 65, Núm. 8, pp. 3264-3272

  4. Cleaning noising from an ECG

    Recent Advances in Multidisciplinary Applied Physics (Elsevier Ltd), pp. 509-518

  5. Cleaning noising from an ECG

    Recent Advances in Multidisciplinary Applied Physics: Proceedings of the First International Meeting on Applied Physics (APHYS-2003) October 13-18th 2003, Badajoz, Spain

  6. Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib

    Cancer Genetics and Cytogenetics, Vol. 160, Núm. 1, pp. 22-26

  7. Células madre adultas en el tratamiento de la regeneración miocárdica

    Actualizaciones en medicina del Hospital Universitario de Canarias (Cabildo Insular de Tenerife), pp. 148-155

  8. Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia [10]

    Leukemia

  9. Erratum: NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2 (Cancer Genetics and Cytogenetics (2005) 157 (151-6))

    Cancer Genetics and Cytogenetics

  10. Fibrinógeno. Vieja proteína hemostática con nueva función: Marcador no invasivo de aterosclerosis subclínica

    Medicina Clinica, Vol. 124, Núm. 20, pp. 790-794

  11. IFN-α gene therapy for woodchuck hepatitis with adeno-associated virus: Differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes

    Molecular Therapy, Vol. 12, Núm. 1, pp. 68-76

  12. Independent association of von Willebrand factor with surrogate markers of atherosclerosis in middle-aged asymptomatic subjects

    Journal of Thrombosis and Haemostasis, Vol. 3, Núm. 4, pp. 662-664

  13. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex

    Vaccine, Vol. 23, Núm. 11, pp. 1384-1392

  14. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis

    Journal of Clinical Oncology, Vol. 23, Núm. 28, pp. 7043-7049

  15. Lack of association of CYP3A4-V polymorphism with the risk of treatment-related leukemia

    Leukemia Research

  16. Medicina regenerativa con células madre adultas

    Revista Clinica Espanola, Vol. 205, Núm. 11, pp. 556-564

  17. Metaloproteasas en aterosclerosis: implicaciones fisiopatológicas y terapéuticas

    Clínica e investigación en arteriosclerosis, Vol. 17, Núm. 3, pp. 133-141

  18. Monocyte cyclooxygenase-2 activity: A new therapeutic target for atherosclerosis?

    Current Drug Targets - Cardiovascular and Haematological Disorders, Vol. 5, Núm. 4, pp. 303-311

  19. Monocyte cyclooxygenase-2 overactivity: A new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?

    European Heart Journal, Vol. 26, Núm. 2, pp. 153-158

  20. Myocardial regeneration: future at reach

    Revista de medicina de la Universidad de Navarra, Vol. 49, Núm. 3, pp. 62-68